Cancer Immunotherapy Stocks List

Recent Signals

Date Stock Signal Type
2019-09-18 ADAP NR7 Range Contraction
2019-09-18 ADAP Calm After Storm Range Contraction
2019-09-18 ADAP Narrow Range Bar Range Contraction
2019-09-18 ADRO Fell Below 20 DMA Bearish
2019-09-18 CKPT Lower Bollinger Band Walk Weakness
2019-09-18 CLBS New Uptrend Bullish
2019-09-18 CLBS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-18 CRVS Narrow Range Bar Range Contraction
2019-09-18 CRVS NR7 Range Contraction
2019-09-18 CRVS MACD Bearish Signal Line Cross Bearish
2019-09-18 FTSV NR7 Range Contraction
2019-09-18 FTSV 20 DMA Support Bullish
2019-09-18 GRTS MACD Bearish Signal Line Cross Bearish
2019-09-18 GRTS MACD Bearish Centerline Cross Bearish
2019-09-18 HARP Fell Below 20 DMA Bearish
2019-09-18 HARP 50 DMA Support Bullish
2019-09-18 IMV Pocket Pivot Bullish Swing Setup
2019-09-18 IOVA 20 DMA Support Bullish
2019-09-18 MBIO Fell Below 20 DMA Bearish
2019-09-18 MBIO MACD Bearish Signal Line Cross Bearish
2019-09-18 MRKR Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-18 MRKR 200 DMA Support Bullish
2019-09-18 MRUS MACD Bullish Signal Line Cross Bullish
2019-09-18 NLNK Pocket Pivot Bullish Swing Setup
2019-09-18 NLNK Volume Surge Other
2019-09-18 NLNK Upper Bollinger Band Walk Strength
2019-09-18 NTGN NR7 Range Contraction
2019-09-18 PDSB Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-09-18 PDSB Pocket Pivot Bullish Swing Setup
2019-09-18 PDSB 1,2,3 Retracement Bearish Bearish Swing Setup
2019-09-18 SURF Fell Below 20 DMA Bearish
2019-09-18 TRIL New Uptrend Bullish
2019-09-18 TRIL Upper Bollinger Band Walk Strength
2019-09-18 ZYME Stochastic Reached Oversold Weakness

Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.

More about Cancer Immunotherapy